Chip stocks enter bear-market territory. A BofA analyst says not to panic.

Journey Medical signals continued ASP gains in 2H 2026 as Emrosi reaches $8.1M and 38% high-quality coverage

Sera outlines 1%-2% Illinois Medicaid penetration in 2027 while targeting 5-7 commercial programs

FlyExclusive expects $5M-$7M adjusted EBITDA in Q3 2026, supported by Jet.AI integration and fleet modernization

NextEra enters deal with U.S., Japanese governments to fund up to 10 GW of gas-powered generation